Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
Vivimed Labs Ltd.
₹5.80
₹5.31
₹5.80
₹5.15
₹29.40
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 11.63 | 18.66 | 17.94 | 22.58 | 34.23 |
| Operating Expense | 22.85 | 19.98 | 18.48 | 25.06 | 34.41 |
| Operating Profit | -11.22 | -1.32 | -0.54 | -2.48 | -0.18 |
| Depreciation | 4.40 | 4.68 | 4.80 | 4.61 | 6.37 |
| Interest | 0.94 | 1.60 | 0.52 | 1.48 | 0.43 |
| Tax | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -16.57 | -7.44 | -5.50 | -4.42 | -6.97 |
₹5.80
↗ Bullish Moving Average
2
↘ Bearish Moving Average
14
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 20.9 | 20.9 | 20.9 | 7.8 | 7.8 | 7.8 |
| FII | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 |
| DII | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Public | 77.3 | 77.3 | 77.3 | 90.5 | 90.5 | 90.5 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 98.35 K | 1.32 L | 74.59% |
| Week | 1.47 L | 1.66 L | 88.39% |
| 1 Month | 1.66 L | 2.01 L | 82.62% |
| 6 Month | 2.03 L | 2.8 L | 72.69% |
Positive Breakout First Resistance ( LTP > R1)
Relative Outperformance versus Industry over 1 Year
PEG lower than Industry PEG
Good Aggregate Candlestick Strength (total bullish - bearish candlesticks)
Effectively using its capital to generate profit - RoCE improving in last 2 years
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Stock with Low PE (PE < = 10)
Biggest Price Gainers from Open
Top Gainers
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 19 Sep, 2018 | 0.4 | FINAL | Equity Share | |
| 21 Sep, 2017 | 0.4 | FINAL | Equity Share | |
| 24 Sep, 2014 | 3 | FINAL | Equity Share | |
| 24 Sep, 2013 | 3 | FINAL | Equity Share | |
| 21 Sep, 2012 | 3 | FINAL | Equity Share | |
| 26 Sep, 2011 | 2 | FINAL | Equity Share | |
| 09 Sep, 2010 | 1.5 | FINAL | Equity Share | |
| 24 Sep, 2009 | 1.5 | FINAL | Equity Share | |
| 22 Sep, 2008 | 1 | FINAL | Equity Share |
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹89.80 | ₹108.50 | ₹112.60 | ₹17.20 | ₹214 |
| % Change | -10.11% | 2.54% | -0.42% | 0.00% | 0.19% |
| Revenue TTM (₹ Cr) | - | ₹282.74 | - | - | - |
| Net Profit TTM (₹ Cr) | - | ₹15.30 | - | - | - |
| PE TTM | 11.90 | 27.40 | - | 5.90 | 37.30 |
| 1 Year Return | -29.73 | -14.23 | 24.34 | -60 | 124.27 |
| ROCE | - | - | - | - | - |
Medicamen Organics Ltd.
₹ 23.25
+4.97%
Amrutanjan Health Care Ltd.
₹ 507.95
+1.69%
Senores Pharmaceuticals Ltd.
₹ 785.00
+1.48%
Innova Captab Ltd.
₹ 703.90
-0.01%
Valiant Laboratories Ltd.
₹ 56.10
-1.48%
Supriya Lifescience Ltd.
₹ 611.00
+1.66%
Sigachi Industries Ltd.
₹ 19.45
-0.10%
Windlas Biotech Ltd.
₹ 766.00
-0.21%
Vineet Laboratories Ltd.
₹ 29.50
+0.10%
Solara Active Pharma Sciences Ltd.
₹ 474.80
+3.42%
Zim Laboratories Ltd.
₹ 69.00
+7.18%
Medico Remedies Ltd.
₹ 38.15
-0.44%
Dishman Carbogen Amcis Ltd.
₹ 146.05
-0.06%
Lasa Supergenerics Ltd.
₹ 6.24
+4.87%
Advanced Enzyme Technologies Ltd.
₹ 272.00
+2.10%
Bajaj Healthcare Ltd.
₹ 308.25
-1.11%
Ortin Global Ltd.
₹ 14.44
+1.48%
Brooks Laboratories Ltd.
₹ 53.43
+19.99%
RPG Life Sciences Ltd.
₹ 1920.00
+2.26%
Bafna Pharmaceuticals Ltd.
₹ 113.99
+1.81%
Alpa Laboratories Ltd.
₹ 54.50
+8.54%
Sun Pharma Advanced Research Company Ltd.
₹ 123.71
+2.80%
SMS Pharmaceuticals Ltd.
₹ 389.00
-0.95%
Nectar Lifesciences Ltd.
₹ 10.01
+2.56%
By signing up I certify terms, conditions & privacy policy